News about genomics analysis tools including next generation sequencing, electrophoresis, PCR, and others
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 30, 2020 WALTHAM, Mass., Jan. 2, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the 2019 fourth quarter and full year before the market opens on Thursday, January 30, 2020,... Read more
Delivering the Largest Commercially Available Collection of Pathologist‑Verified Antibodies for Imaging Mass Cytometry SOUTH SAN FRANCISCO, Calif., Dec. 10, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM), the global leader in high-multiplex single-scan tissue imaging, today announced the availability of more than 100 pathologist-verified Maxpar® antibodies for use with Imaging Mass Cytometry™ (IMC™) on the Hyperion™ Imaging System. This expanding collection now includes... Read more
CHICAGO– December 1, 2019 – GE Healthcare today launched more than 30 new, imaging intelligent applications and smart devices designed to drive efficiency in radiology departments, aiming to double productivity and cost savings for systems by 2025. For healthcare executives, the new offerings help systems to save costs, improve technology utilization, and increase patient volumes.... Read more
CHICAGO– December 1, 2019 – GE Healthcare today launched more than 30 new, imaging intelligent applications and smart devices designed to drive efficiency in radiology departments, aiming to double productivity and cost savings for systems by 2025. For healthcare executives, the new offerings help systems to save costs, improve technology utilization, and increase patient volumes.... Read more
CHICAGO– December 1, 2019 – GE Healthcare today launched more than 30 new, imaging intelligent applications and smart devices designed to drive efficiency in radiology departments, aiming to double productivity and cost savings for systems by 2025. For healthcare executives, the new offerings help systems to save costs, improve technology utilization, and increase patient volumes.... Read more
Thermo Fisher Scientific Introduces Latest Forensic Laboratory-Qualified Capillary Electrophoresis Platform Applied Biosystems SeqStudio Genetic Analyzer for Human Identification brings trusted technology and validated workflow to forensic DNA laboratories SOUTH SAN FRANCISCO, Calif., Nov. 20, 2019 /PRNewswire/ — Forensic scientists now have access to the Applied Biosystems SeqStudio Genetic Analyzer for Human Identification, an affordable and... Read more
EDEN PRAIRIE, Minn., Nov. 11, 2019 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems, motion simulators and sensors, today announced that it will release its fourth quarter results on November 25, 2019 after market close. A conference call will be held on November 26, 2019 at 10:00 a.m. ET (9:00... Read more
Thermo Fisher Scientific Introduces First Next-Generation Sequencing Platform That Delivers Specimen to Report in a Single Day Ion Torrent Genexus System* holds potential to advance precision medicine in the clinic BALTIMORE, Nov. 6, 2019 /PRNewswire/ — Thermo Fisher Scientific announced the launch of its Ion Torrent Genexus System, the first fully integrated, next-generation sequencing (NGS) platform... Read more
QIAseq® Multimodal Panels streamline simultaneous DNA and RNA sequencing for comprehensive solid and liquid tumor profiling Only solution to extract, enrich and sequence DNA variants and RNA fusions and assess gene expression in a single workflow from a single sample within a single day QIAGEN to highlight extensive Sample to Insight portfolio for clinical laboratories... Read more
Third quarter 2019 reported net income was $65 million or $0.36 per share; Adjusted net income for the quarter was $149 million or $0.82 per share, up 10% excluding foreign exchange translation Delivered $1.3 billion in revenue for the third quarter, up 3% organically Lowers full-year 2019 organic revenue growth guidance range to 3% to... Read more